Figure 1 from Defining distinct features of anti-MOG antibody associated central nervous system demyelination | Semantic Scholar
MOG Antibody Disease - Practical Neurology
IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype | Journal of Neuroinflammation | Full Text
IJMS | Free Full-Text | Predictive Value of Serum Antibodies and Point Mutations of AQP4, AQP1 and MOG in A Cohort of Spanish Patients with Neuromyelitis Optica Spectrum Disorders
Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020
MOG antibody demyelination | Great Ormond Street Hospital
MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation | SpringerLink
MSParis2017: MOG-associated Demyelination Can Be Treated with Steroids